Oscar Health, Inc. (OSCR) stock
OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3026% above fair value
$27.57−2.27 (-7.61%)
Close on Nov 18, 2026Market cap $8.51BP/E 19.7Yield –
Oscar Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Oscar Health's operating cash flow for the twelve months ending Jun 30, 2026 was $4.42B, up 258.0% year over year. For fiscal 2025 it was $1.09B, up 11.9% from the year before. The highest annual figure on record is $1.09B in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.09B | +11.9% |
| FY2024 | Dec 31, 2024 | $978.19M | – |
| FY2023 | Dec 31, 2023 | -$272.16M | -171.6% |
| FY2022 | Dec 31, 2022 | $380.35M | – |
| FY2021 | Dec 31, 2021 | -$181.75M | -181.6% |
| FY2020 | Dec 31, 2020 | $222.73M | – |
| FY2019 | Dec 31, 2019 | -$165.37M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.09B | +311.0% |
| Q1 FY2026 | Mar 31, 2026 | $2.62B | +198.1% |
| Q4 FY2025 | Dec 31, 2025 | $671.90M | +93.7% |
| Q3 FY2025 | Sep 30, 2025 | -$964.66M | – |
| Q2 FY2025 | Jun 30, 2025 | $509.07M | +2.4% |
| Q1 FY2025 | Mar 31, 2025 | $878.54M | +38.5% |
| Q4 FY2024 | Dec 31, 2024 | $346.82M | +16.8% |
| Q3 FY2024 | Sep 30, 2024 | -$500.14M | – |
| Q2 FY2024 | Jun 30, 2024 | $497.15M | +200.3% |
| Q1 FY2024 | Mar 31, 2024 | $634.36M | +53.0% |
| Q4 FY2023 | Dec 31, 2023 | $296.87M | +96.1% |
| Q3 FY2023 | Sep 30, 2023 | -$1.15B | – |
| Q2 FY2023 | Jun 30, 2023 | $165.52M | -22.8% |
| Q1 FY2023 | Mar 31, 2023 | $414.72M | -26.3% |
| Q4 FY2022 | Dec 31, 2022 | $151.39M | +339.1% |
| Q3 FY2022 | Sep 30, 2022 | -$548.36M | – |
| Q2 FY2022 | Jun 30, 2022 | $214.47M | +287.6% |
| Q1 FY2022 | Mar 31, 2022 | $562.85M | +77.2% |
| Q4 FY2021 | Dec 31, 2021 | $34.48M | -61.3% |
| Q3 FY2021 | Sep 30, 2021 | -$589.25M | – |
| Q2 FY2021 | Jun 30, 2021 | $55.34M | -77.5% |
| Q1 FY2021 | Mar 31, 2021 | $317.69M | +198.7% |
| Q4 FY2020 | Dec 31, 2020 | $88.98M | – |
| Q3 FY2020 | Sep 30, 2020 | -$218.92M | – |
| Q2 FY2020 | Jun 30, 2020 | $246.32M | – |
| Q1 FY2020 | Mar 31, 2020 | $106.35M | – |
See a number that looks wrong?